BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
7.8550
12-November-24 14:08:27
15 minutes delayed
Stocks
-0.3350
-4.09%
Today's range
7.8300 - 8.2400
ISIN
N/A
Source
NASDAQ
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 Feb 2023 06:00:30 By Nasdaq GlobeNewswire
-
03 Feb 2023 06:00:00 By Nasdaq GlobeNewswire
-
26 Jan 2023 06:00:01 By Nasdaq GlobeNewswire
-
23 Jan 2023 06:00:00 By Nasdaq GlobeNewswire
-
09 Jan 2023 06:05:55 By Nasdaq GlobeNewswire
-
09 Jan 2023 06:00:40 By Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 Jan 2023 06:00:28 By Nasdaq GlobeNewswire
-
BioCryst to Present at 41st Annual J.P. Morgan Healthcare Conference
04 Jan 2023 06:00:46 By Nasdaq GlobeNewswire
-
15 Dec 2022 06:00:00 By Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 Dec 2022 15:01:09 By Nasdaq GlobeNewswire
-
BioCryst to Present at JMP Securities Hematology & Oncology Summit
05 Dec 2022 06:00:26 By Nasdaq GlobeNewswire
-
BioCryst Announces Approval of ORLADEYO® (berotralstat) by the Israeli Ministry of Health
28 Nov 2022 06:00:43 By Nasdaq GlobeNewswire
-
10 Nov 2022 07:00:21 By Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conferences
09 Nov 2022 06:00:33 By Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 Nov 2022 06:00:46 By Nasdaq GlobeNewswire
-
BioCryst Reports Third Quarter 2022 Financial Results and Upcoming Key Milestones
01 Nov 2022 06:00:35 By Nasdaq GlobeNewswire
-
24 Oct 2022 06:00:00 By Nasdaq GlobeNewswire
-
BioCryst to Report Third Quarter 2022 Financial Results on November 1
18 Oct 2022 06:00:39 By Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 Oct 2022 06:00:45 By Nasdaq GlobeNewswire
-
14 Sep 2022 15:01:10 By Nasdaq GlobeNewswire